CIK 0000899460
- Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133607736
- Phone
- +1 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- 4 Grant or award Chief Executive Officer acquired 565,000 shares (grant or award)
- 4 Grant or award EVP Endocrine Business Unit acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP Genl Counsel & Secretary acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief People & Workpl Officer acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 36,900 shares at $2.71 ($99,999)
- 4 Open-market buy Director bought 40,000 shares at $2.71 ($108,400)
- 4 Open-market buy Director bought 27,675 shares at $2.71 ($74,999)
- 4 Open-market buy Chief People & Workpl Officer bought 9,225 shares at $2.71 ($25,000)
- 4 Open-market buy Chief Executive Officer bought 27,675 shares at $2.71 ($74,999)
- 4 Open-market buy Director bought 110,701 shares at $2.71 ($300,000)
Page 12 of 50 · 999 filings